NCT06503588 Ureteral Stent Exchange Abstention in Urinary Tract Infections
| NCT ID | NCT06503588 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Central Hospital, Nancy, France |
| Condition | Urinary Tract Infections |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2024-07-01 |
| Primary Completion | 2025-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2024-07-01 with a primary completion date of 2025-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Committee of Infectiology of the French Association of Urology (CIAFU) provided, for the first time in 2020, comprehensive guidelines for ureteral stent-associated urinary tract infections (USAUTI) prevention, diagnosis and treatment. Since evidence lacked in terms of appropriate treatment, guidelines could not support systematic change of US in case of USAUTI. This study aims to evaluate whether "after guidelines group" patients treated for USAUTI had different occurrence of at least one relapse or recurrence than "before guidelines group".
Eligibility Criteria
Inclusion Criteria: * All patients with indwelling ureteral catheter * AND confirmed or probable urinary tract infection Exclusion Criteria: * Patient's opposition * History of ileal conduit urinary diversion * Second or more urinary tract infection during the study period
Contact & Investigator
+33383154097 Lefevre, M.D. PhD
PRINCIPAL INVESTIGATOR
Central Hospital, Nancy, France
Frequently Asked Questions
Who can join the NCT06503588 clinical trial?
This trial is open to participants of all sexes, studying Urinary Tract Infections. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06503588 currently recruiting?
Yes, NCT06503588 is actively recruiting participants. Contact the research team at b.lefevre@chru-nancy.fr for enrollment information.
Where is the NCT06503588 trial being conducted?
This trial is being conducted at Nancy, France.
Who is sponsoring the NCT06503588 clinical trial?
NCT06503588 is sponsored by Central Hospital, Nancy, France. The principal investigator is +33383154097 Lefevre, M.D. PhD at Central Hospital, Nancy, France. The trial plans to enroll 300 participants.